To the Editor.—
We read with interest the report by Nimer and coworkers1 demonstrating that granulocyte-macrophage colony-stimulating factor (GM-CSF) lowers serum cholesterol when administered by infusion to patients with aplastic anemia. The authors postulate a number of potential mechanisms whereby GM-CSF may alter cholesterol metabolism. We agree with their hypothesis that the action of GM-CSF on hepatic cholesterol biosynthesis is most likely indirect and mediated via liver cells of monocyte-macrophage lineage. However, we would like to suggest an alternative mechanism not addressed in their report.We propose that the hypocholesterolemic effect of GM-CSF is related to the simulation of inflammatory cytokines. Sisson and Dinarello2 have recently demonstrated that recombinant GM-CSF stimulates the production of interleukin 1α, interleukin β, and tumor necrosis factor from normal human mononulcear cells. Interleukin 1, the protein mediator of the acute phase response, has a number of metabolic effects, including stimulation of resting energy
Mazur EM, Herbert PN. Lowering Cholesterol With Granulocyte-Macrophage Colony-Stimulating Factor. JAMA. 1989;261(16):2332. doi:10.1001/jama.1989.03420160055025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: